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Abstract
Neurodegeneration is an age-related disorder which is characterised by the accumulation of aggregated protein and
neuronal cell death. There are many different neurodegenerative diseases which are classified according to the specific
proteins involved and the regions of the brain which are affected. Despite individual differences, there are common
mechanisms at the sub-cellular level leading to loss of protein homeostasis. The two central systems in protein homeostasis
are the chaperone system, which promotes correct protein folding, and the cellular proteolytic system, which degrades
misfolded or damaged proteins. Since these systems and their interactions are very complex, we use mathematical
modelling to aid understanding of the processes involved. The model developed in this study focuses on the role of Hsp70
(IPR00103) and Hsp90 (IPR001404) chaperones in preventing both protein aggregation and cell death. Simulations were
performed under three different conditions: no stress; transient stress due to an increase in reactive oxygen species; and
high stress due to sustained increases in reactive oxygen species. The model predicts that protein homeostasis can be
maintained during short periods of stress. However, under long periods of stress, the chaperone system becomes
overwhelmed and the probability of cell death pathways being activated increases. Simulations were also run in which cell
death mediated by the JNK (P45983) and p38 (Q16539) pathways was inhibited. The model predicts that inhibiting either or
both of these pathways may delay cell death but does not stop the aggregation process and that eventually cells die due to
aggregated protein inhibiting proteasomal function. This problem can be overcome if the sequestration of aggregated
protein into inclusion bodies is enhanced. This model predicts responses to reactive oxygen species-mediated stress that
are consistent with currently available experimental data. The model can be used to assess specific interventions to reduce
cell death due to impaired protein homeostasis.
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Introduction
Cellular proteins are subject to oxidative damage and must
either be repaired or removed to maintain protein homeostasis.
Cells possess two main mechanisms to deal with damaged protein.
The first mechanism is the chaperone system. Chaperones such as
Hsp70 and Hsp90 bind to exposed hydrophobic regions of
misfolded proteins and assist in the refolding process. Secondly, if
refolding is unsuccessful, the misfolded protein is removed by the
cellular proteolytic systems. The main system for removal of
damaged and/or misfolded proteins is the proteasome, although
autophagy also plays a role. If either the chaperone system or
degradation pathways are perturbed, damaged protein may
accumulate and start to form aggregates. Aggregated protein has
been implicated in age-related neurodegenerative disorders
although there is still controversy over whether it is a cause or
consequence of the disease process [1]. Small aggregates bind to
proteasomes but are unable to be degraded and so inhibit
proteasomal function [2]. This will lead to a reduction in the
clearance of misfolded protein and a vicious cycle might ensue.
Levels of reactive oxygen species (ROS) increase with age due to
either an increase in dysfunctional mitochondria or a decline in
the antioxidant system [3,4] leading to increase damage to cellular
components. In addition it has been observed that there is a
progressive decline in the overall proteolytic capacity of the cell
with age [5,6] resulting in an accumulation of oxidized and cross-
linked proteins [7,8]. Chaperone function has also been shown to
decline with age [9,10]. There are several links between the
chaperone and degradation pathways. For example, the molecular
co-chaperone CHIP (C terminus of Hsc70-interacting protein,
(Q9UNE7)) serves as a catalyst for the ubiquitination of several
Hsp70 and Hsp90 client proteins that have been linked to
neurodegenerative disorders [11]. Therefore, interventions which
target part of one pathway will also impact the rest of the system.
A stochastic model of the chaperone Hsp90 was previously
developed to examine the role of chaperones in the ageing process
[12]. This model showed that under conditions of low or transient
stress, chaperone capacity is sufficient to maintain protein
homeostasis. Even under conditions of increasing stress with age,
normal chaperone capacity is able to deal with the increasing
overload due to the mechanism of upregulation of Hsps after
stress. However, if the model includes a decline in chaperone
function with age, then the system becomes overwhelmed and
protein homeostasis is lost. This model only included Hsp90 and
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one client of Hsp90, namely Heat Shock Factor-1 (Hsf1,
(Q00613)) but was constructed in the Systems Biology Mark-up
Language (SBML) [13] which allows easy extension as required.
The role of apoptosis in ageing has received considerable
interest but the exact relationship between ageing and apoptosis
has yet to be established [14]. Apoptosis has a critical role in tissue
homeostasis, and in mitotic tissue is important for preventing
tumorigenesis. In post-mitotic tissue, ageing is associated with
increased apoptosis to remove dysfunctional cells and since these
cells are irreplaceable, this will have an impact on tissue function.
For example, neuronal loss is a common feature of neurodegen-
eration and results in pathology such as memory loss, movement
disorders and/or visual impairment, depending on the specific
part of the brain which is affected. Therefore it is important to
extend the model to include apoptotic pathways. Many chaper-
ones are involved in apoptotic pathways such as Hsp27 and Hsp70
which are antiapoptotic. There are many pathways involved in
apoptosis but our model will concentrate on three pathways that
are particularly relevant to neurodegeneration. The first pathway
involves the c-Jun N-terminal kinase (JNK). JNK (MAPK8) is
activated by phosphorylation and in turn, JNK phosphorylates a
number of proteins involved in various signalling pathways
including apoptosis. It is maintained in an inactive state by the
phosphatase Mkp1 (DUSP1, (P28562)) which requires Hsp70 for
its activation. When levels of free Hsp70 are high, Mkp1 is
activated and JNK activation is inhibited. Under conditions of
stress, misfolded protein binds to Hsp70, diminishing pools of free
Hsp70, so less Mkp1 is activated. Therefore, JNK remains
phosphorylated and can induce one of the signalling pathways
which lead to apoptosis. In this model we assume that the
probability of cell death depends on the level of activated JNK,
with the understanding that future models could incorporate more
additional regulatory elements. Upregulation of Hsp70 by the
stress response maintains pools of free Hsp70 to prevent activation
of this apoptotic pathway. Mkp1 is prone to oxidation in its
catalytic domain resulting in inactivation of its phosphatase
activity [15]. This means that ROS elevation has opposing effects
on Mkp1 activity. On the one hand, increased pools of Hsp70
leads to activation of Mkp1, but on the other hand oxidation of
Mkp1 by ROS leads to its inactivation. These opposing effects of
ROS are incorporated into the model.
The second apoptotic pathway considered involves the mitogen-
activated protein kinase p38 (MAPK14). It has been shown that
p38 is activated by an increase in levels of ROS [16], and that p38
is also involved in generating ROS, so providing a positive
feedback loop [16,17,18]. Similarly to JNK, p38 is de-phosphor-
ylated by Mkp1 to keep it in an inactive state. As for JNK, we
model this apoptotic pathway by assuming that the probability of
cell death depends on the level of activated p38. The third
apoptotic pathway that we include involves the transcription factor
p53 (P04637) which is normally present in low levels as it is rapidly
turned over by the ubiquitin-proteasome pathway. However, if the
proteasome is inhibited, levels of p53 will rise and either cell cycle
arrest (relevant only for dividing cells) or apoptosis takes place. We
do not include details of the p53 apoptotic pathway in this model
as this pathway is very complex and would also have needed to
include detail of p53 turnover. This extra complexity would have
made stochastic simulations and model analysis impractical to do
in terms of the computer simulation time required. Therefore, for
simplicity we assume that the probability of cell death depends on
the level of aggregated protein inhibiting the proteasome.
Akt (P31749) is a kinase which plays an important role in
cellular signalling and it is involved in survival pathways. It is a
client of Hsp90 and is destabilised by inhibitors of Hsp90 function
[19]. It phosphorylates glycogen synthase kinase-3 beta (GSK3b,
(P49841)) [20], one of the main kinases responsible for tau
(P10636) hyperphosphorylation. A model of tau aggregation is also
being developed with the intention of linking it to this model of
chaperones and so we include Akt as a common link for these
models. Hsp90 inhibitors, such as geldamycin, bind tightly to the
Hsp90 ATP/ADP pocket and prevent ATP binding and the
completion of client protein refolding. Instead proteins are
degraded. For example, Basso et al. [19] found that Hsp90
inhibitors do not alter association of Akt with Hsp90 but result in
ubiquitination of Akt and its subsequent degradation. They found
that the half-life of Akt was shortened from 36 hours to 12 hours
in cells exposed to the Hsp90 inhibitor 17-AAG.
Here we have extended the chaperone model of Proctor et al.
[12] to include details of Hsp70 and its role in apoptosis, as well as
its chaperoning activity. We also include detail of some of the
client proteins of Hsp70 and Hsp90. We hypothesize that: (1)
under normal conditions, basal levels of chaperones are able to
maintain protein homeostasis; (2) under conditions of low or
moderate stress, there is a transient increase in protein misfolding
but chaperones are upregulated and protein homeostasis is
restored; and (3) under conditions of prolonged high stress, the
chaperone system is overwhelmed and apoptosis takes place. We
now give more details of each of these scenarios.
(1) Normal conditions -unstressed cells
Under normal cellular conditions (Figure 1) there are very low
levels of damaged/misfolded protein which are either refolded via
the chaperone system or eliminated from the cell via the ubiquitin-
proteasome system. The majority of Hsf1 is bound to Hsp90 which
prevents Hsf1 from becoming transcriptionally active. There is
basal transcription of heat shock proteins to maintain pools at a
steady state level but there is no upregulation of Hsps. JNK and
p38 are maintained in their unphosphorylated state due to activity
of the phosphatase Mkp1, which requires Hsp70 for its activity.
Since there are sufficient pools of free Hsp70, apoptosis is
inhibited. Figure 1 omits detail of JNK for clarity. (Note that
Figures 1, 2, 3 are biological diagrams that summarise the key
components of the model. A diagram of the full model network is
shown in Figure S1).
(2) Low – moderate levels of stress
When cells are stressed (Figure 2), damaged/misfolded proteins
accumulate and bind to Hsp70 and Hsp90. Once bound to
chaperones, they may be refolded or sent for degradation. Binding
of misfolded proteins to chaperones also prevents their aggrega-
tion. Due to competition from misfolded proteins, Hsf1 is released
from Hsp90 and its concentration is now sufficient for it to form
trimers. Hsf1 trimers are phosphorylated and become transcrip-
tionally active so Hsps are upregulated. Hsp70 also binds to a
phosphatase (currently unknown and so is referred to as PPX)
which will dephosphorylate the trimers. This occurs when the
concentration of free Hsp70 is sufficiently high and provides a
negative feedback loop to prevent further upregulation of Hsps
when they are present in sufficient number. This also provides a
mechanism to switch off transcription of Hsps once the stress is
over. There is sufficient Hsp70, despite some of the pool binding to
misfolded protein, to continue to keep Mkp1 active and so prevent
apoptosis.
(3) High levels of stress
If cells are subject to high levels of stress over long time periods
(Figure 3), there will be a large increase in misfolded proteins
which bind to the pool of free Hsp70 and Hsp90. Upregulation of
Modelling Hsp70/Hsp90 in Protein Homeostasis
PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e22038
Hsps will occur but eventually the chaperone system is
overwhelmed and free pools are severely depleted. The idea of
an overload of the chaperone system has been previously proposed
and so we will use our model to test this hypothesis [21]. There is
also experimental evidence that chaperone systems are over-
whelmed during periods of high stress. For example, Sangster et al.
have shown that elevated temperature can phenocopy the effects
of Hsp90 inhibition on genetic trait selection in Drosophila. This is a
consequence of heat-induced widespread misfolding of proteins
overwhelming the Hsp90 chaperone system and thereby prevent-
ing it from assisting in a subset of proteins that require Hsp90 to
fold correctly under non-stressed conditions [22]. Cowen and
Lindquist have made similar observations in yeast cells [23]. An
overload of the chaperone system leads to depletion of free pools of
Hsp70 which allows phosphorylation of JNK and p38 and
subsequently leads to apoptosis. There may also be an increase
in aggregated protein if there is insufficient Hsp70 and Hsp90 to
bind to the misfolded proteins. In addition, activation of p38 leads
to increased ROS and so even more protein misfolding occurs. It
has been shown that damaged protein accumulates with age in
post-mitotic cells, and in addition, there is also an age-related
increase in dysfunctional mitochondria leading to increased levels
of ROS. All these factors may explain why the risk of
neurodegenerative disorders increases with age.
Results
The purpose of building the model is to test the following
hypotheses: (1) protein homeostasis is maintained during periods of
low or moderate levels of stress; (2) protein homeostasis is
disturbed after prolonged high levels of stress leading to cell death
due to an overload of the chaperone system. Therefore we ran the
model under three different scenarios: normal conditions (no
stress); a transient increase in ROS (moderate stress); and with
increasing stress with time (high stress).
Normal conditions (no stress)
We set the model parameters so that under normal conditions
levels of all proteins remain fairly constant, there is no
upregulation of Hsps and no activation of JNK or p38. A typical
simulation result is shown in Figure 4. As we have used stochastic
simulation, we carried out multiple runs and plotted the mean
values for 100 simulations (Figure S2). The model for unstressed
conditions was also run in a deterministic simulator and produces
very similar results to the stochastic model (Figure S3).
Transient increase in ROS (moderate stress)
We ran stochastic simulations in which we increased ROS
levels four-fold for a period of 1 hour (Figure 5). Deterministic
simulation produced similar results to the stochastic model (Figure
S4). After ROS levels increase (at time= 4 hours), there is an
increase in misfolded protein which binds to Hsp70 and Hsp90.
The model predicts that initially there are sufficient pools of
unbound Hsps and so clients including Hsf1 remain bound to
Hsp70 and Hsp90. As pools of unbound Hsps become depleted,
misfolded protein competes with the client proteins but very little
Hsf1 is released from its complex since the binding affinity of Hsf1
to Hsp90 is much greater than the binding affinity of other clients.
So the model predicts only a very small increase in total Hsp levels.
The misfolded protein is either refolded or degraded and replaced
with newly synthesised protein so that by 2 hours after ROS levels
have returned to normal, protein homeostasis is restored. We also
looked at the effect in varying the amount and duration of stress by
modifying the events for increasing and decreasing stress so that
ROS was increased by a factor of 2, 4 or 8 for a period of 1, 2, 3 or
4 hours. The time to recovery under each condition was
Figure 1. Network structure of model for unstressed cells. Under normal conditions, free pools of Hsp70 and Hsp90 are high and pools of
misfolded protein are low. Hsp90 is bound to Hsf1 to prevent transcription of heat shock genes. Hsp70 activates Mkp1 which leads to
dephosphorylation of JNK and p38, so that apoptotic pathways are not activated. Thickness of lines indicates most likely reactions and states.
doi:10.1371/journal.pone.0022038.g001
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calculated and was assumed to be the time taken for the total level
of misfolded protein after the stress event to return to within one
standard deviation of the mean level of misfolded protein before
the stress event. The model predicts that increasing the duration of
stress leads to a shorter time of recovery for all stress levels
(Table 1). This was due to greater upregulation of Hsps which
persisted even after the stress was over. Increasing the amount of
stress from two-fold to four-fold increased the amount of misfolded
protein but also increased the amount of heat shock proteins so
that the time for recovery was also shortened. However, an 8-fold
increase in the amount of ROS led to longer recovery times
compared to a 4-fold increase when the duration of stress was 1, 2
or 3 hours. This was due to a much larger increase in misfolded
proteins which outnumbered the pool of heat shock proteins.
Increasing ROS with time (high stress)
We replaced a constant rate of ROS production with a rate that
increases linearly with time (Figure S5). This was achieved by
including the time variable in the rate law (see Methods). As the
results for this situation are very variable it was necessary to do 100
simulations. We ran the simulation for 48 hours (simulated time)
and the model predicted that 74% cells died during this period.
The cause of death was recorded and in this set of simulations,
32% of cell deaths are due to the p38 pathway and 42% due to the
JNK pathway. Since we assume that the reaction rates for both
pathways are equal, we would expect the number of deaths by
each pathway to be equal to 37. If we assume that the number of
deaths in 100 simulations follows a Poisson distribution with mean
37, then the standard deviation is 6.1. So obtaining 32 and 42 cell
deaths via the p38 and JNK pathways respectively is due to
stochastic effects. Cell death takes place due to insufficient free
Hsp70 for the activation of Mkp1 which is required to prevent
phosphorylation of both JNK and p38. There are no cell deaths
due to proteasome inhibition, as even in cells which survive,
48 hours is insufficient for aggregates to start accumulating. Cell
death occurs at variable times ranging from 0.4 to 47.4 hours with
the median time to death equal to 34.4 hours which corresponds
to the time at which ROS levels reached about 10 times the basal
level (Figure 6). The model predicts that as ROS levels increase,
there is also an increase in misfolded protein and levels of total
protein decrease due to an increase in degradation of misfolded
protein. The pools of free Hsp70 and Hsp90 decline to low levels
but then start to increase again due to upregulation of Hsps.
However, there are insufficient chaperones to deal with the
overwhelming burden of misfolded protein or to inhibit cell death
pathways.
Deterministic model – ROS increasing with time
Deterministic simulation for the model with increasing ROS
with time was carried out using CellDesigner and COPASI. For
this set of conditions the deterministic and stochastic models give
incomparable results. The deterministic model predicts that the
time to cell death is 38.8 h (Figure S6) and gives no information on
the variability in the time to death. It should be noted that the way
the deterministic simulator models cell death is quite different to
the stochastic method. In the deterministic simulation, the species
Figure 2. Network structure of model for low or moderate levels of stress. Under conditions of low or moderate stress, pools of misfolded
protein increase and bind to Hsp70 and Hsp90 in competition with other substrates. This leads to increased pools of Hsf1 which can now form
trimers. The trimers are then activated resulting in transcription of Hsps. Since pools of Hsp70 are increased, there is still sufficient Hsp70 to prevent
apoptosis.
doi:10.1371/journal.pone.0022038.g002
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variable CellDeath represents the sum of p38Death, JNKDeath
and PIDeath and gradually increases with time until it reaches a
value of 1.0 when the simulation stops. In the stochastic
simulation, CellDeath remains at zero until a cell death pathway
is activated by p38, JNK or proteasome inhibition and then
changes to 1.0 and the simulation stops. Despite these differences,
the deterministic version is useful for looking at the effect of each
parameter on the timing of cell death (see below).
Inhibition of JNK and p38 cell death pathways
Simulations in which ROS levels increase with time were
carried out with inhibition of cell death pathways via JNK and p38
in order to examine if protein aggregation occurs over longer time
periods. The model predicts that aggregates start to form and bind
to the proteasome at about 24 hours but it takes four or five days
before levels at the proteasome are high enough to cause cell death
(Figure 7). Cell death by 8 days occurs in about 80% of
simulations, with the earliest time of death occurring at 55.7 hours
and median time to death equal to about 5.7 days. Interestingly, in
some simulation runs, aggregates are sequestered into inclusion
bodies and if this starts to happen before aggregates bind to the
proteasome, then all further aggregates get sequestered and cell
death via proteasome inhibition is prevented (Figure 7F). If the
parameter for upregulation of Hsps is increased, then the model
predicts that aggregates take much longer to form as more
misfolded proteins are able to bind to Hsp70 and Hsp90 which
prevents their aggregation. Alternatively, if the parameter for
sequestering of aggregates is increased by a factor of two or more,
then proteasome inhibition is prevented. Therefore the model
predicts that inhibition of cell death pathways via p38 or JNK may
not be beneficial unless levels of misfolded and aggregated protein
can also be reduced. Since kupregHsp and kseqagg have an effect on
protein aggregation, we also checked whether changing these
parameters had an effect on the time to cell death. In the model
which includes JNK and p38 death pathways, neither parameter
has an effect on the time to cell death. However, when both JNK
and p38 death pathways are inhibited, varying kseqagg, from half to
double its initial value, did affect the predicted time to cell death in
the deterministic model (Figure S7). Varying kupregHsp over the same
range had little effect on time to cell death, and it was necessary to
decrease (and increase) its value over two orders of magnitude to
see an effect (Figure S8).
Figure 3. Network structure of model for high levels of stress. Under conditions of high or prolonged stress, high levels of misfolded protein
may overwhelm the chaperone system. Although upregulation of Hsps takes place, pools of Hsp70 may be insufficient to activate Mkp1 and so there
is a high probability that apoptosis will take place.
doi:10.1371/journal.pone.0022038.g003
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Effect of relative change in the JNK and p38 rate
constants
We assumed that cell death pathways via p38 and JNK have
equal probability of being activated and which pathway was
activated was determined by stochastic effects. This may not be the
case in reality and so we investigated the effect of relative changes
in the JNK and p38 rate constants. We lowered kp38death by 50%
and increased kJnkdeath by 50% so that the overall death rate
remained the same and carried out 100 simulations. The model
predicts that 58 simulated cells die due to the JNK pathway, 22
simulated cells die due to the p38 pathway and 20 simulated cells
remain alive by 48 hours. The median time to cell death is
27.3 hours (range 0.4–47.7 hours). The cells which are still alive
are included in the calculation for the median since we assume that
if we carried out simulations for longer time periods all cells would
die and the time of later deaths does not affect the median value
(provided more than 50% of cells have died) unlike the effect on
the mean. The median time to cell death when the JNK and p38
constant rates are equal is 34.4 hours, so changing the relative
rates results in earlier cell death. In addition, 100 simulations were
carried out in which kp38death was increased by 50% and kJnkdeath
decreased by 50%. In this scenario, the model predicts 19 deaths
due to JNK pathway, 64 deaths due to p38 pathway and 17 cells
still surviving by 48 h with median time to cell death equal to
31.9 hours (range 0.4–47.7 hours). So again the model predicts
earlier cell death if one pathway has a greater probability of being
activated than when both death pathways have equal probabilities.
Hsp90 inhibition
The use of Hsp90 inhibitors have been proposed as a potential
beneficial therapy in neurodegenerative diseases (recently reviewed
in [24]). Hsp90 inhibitors release Hsf1 from Hsp90 resulting in
upregulation of heat shock proteins, and in addition they promote
the degradation of Hsp90 clients. This works by blocking the
ATPase activity of Hsp90 so that instead of clients being refolded
they are targeted for degradation. As already mentioned, the half-
life of Akt is reduced from about 36 hours to 12 hours after the
addition of an Hsp90 inhibitor [19]. To model the effects of Hsp90
inhibition we set the parameters for Hsp90/Hsf1 binding and for
the release of Hsp90 from its clients (Hsp90client and Akt) to zero
after one hour of simulation time using an event structure (see
Table 2). In order to check that Hsp90 affects the half-life of Akt
we set the synthesis rate for Akt to zero and ran the model with
and without Hsp90 inhibition. The model predicts that the half-
life of Akt is reduced from 36.2 hours to 13.7 hours when Hsp90 is
inhibited, in agreement with the experimental data. When we
Figure 4. Simulation results for normal conditions. One typical simulation result showing levels of some of the model species. A Native protein,
total misfolded protein (includes misfolded bound by Hsps), and reactive oxygen species (ROS). ROS are scaled x100 to allow easier visualisation. B
Total Hsp90 (free pools plus all complexes), Free Hsp90 (unbound Hsp90) and Hsp90_MisP (Hsp90 bound to misfolded protein). C Total Hsp70 (free
pools plus all complexes), Free Hsp70 (unbound Hsp70) and Hsp70_MisP (Hsp70 bound to misfolded protein).
doi:10.1371/journal.pone.0022038.g004
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Figure 5. Simulation results for moderate/transient stress. ROS levels were increased by a factor of 4 at time t = 4 hours for a period of
2 hours. One typical simulation result is shown. A Native protein, total misfolded protein (includes misfolded bound by Hsps), and reactive oxygen
species (ROS). ROS are scaled x100 to allow easier visualisation. B Total Hsp90 (free pools plus all complexes), Free Hsp90 (unbound Hsp90) and
Hsp90_MisP (Hsp90 bound to misfolded protein). C Total Hsp70 (free pools plus all complexes), Free Hsp70 (unbound Hsp70) and Hsp70_MisP
(Hsp70 bound to misfolded protein).
doi:10.1371/journal.pone.0022038.g005
Table 1. Simulation results of varying the amount and duration of a transient increase in ROS levels.
Duration of
stress (h) Fold increase
Time for
recovery (h)
Maximum level of
misfolded protein
Maximum level of
total Hsps
1 2 3.24 1554.3 4377.2
2 2 2.76 1682.9 4383.6
3 2 2.46 1699.3 4394.4
4 2 2.27 1699.3 4404.5
1 4 3.06 2771.6 4398.9
2 4 2.69 3082.5 4435.8
3 4 2.43 3101.1 4470.8
4 4 2.24 3101.1 4503.6
1 8 3.12 5060.5 4467.1
2 8 3.02 6025.4 4713.0
3 8 2.74 6104.0 4939.1
4 8 2.06 6104.0 5030.8
doi:10.1371/journal.pone.0022038.t001
Modelling Hsp70/Hsp90 in Protein Homeostasis
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restore Akt synthesis, the model predicts a decline in Akt pools if
Hsp90 is inhibited. There is also an increase in Hsp70 and Hsp90
pools due to the upregulation of heat shock proteins after Hsp90
inhibition. The effects of Hsp90 inhibition under conditions of
high stress (ROS increases linearly with time) was also examined.
In this case, the model predicts that there is no significant effect on
the percentage of cell deaths or the timing of cell death. However,
the current model does not specifically include Hsp90 clients such
as GSK3b or mutant tau which like Akt are regulated by Hsp90
via CHIP. We would expect that inhibition of Hsp90 would lead
to a decline in GSK3b and mutant tau levels and so we would
predict a reduction in cell death. On the other hand Akt inhibits
GSK3b activity and so GSK3b may become more active even if
actual protein levels are reduced. Therefore it will be of interest to
add further detail to the model to test these predictions.
Model analysis
1. Parameter scan for model under normal
conditions. Many of the parameters in the model are estimated
based on knowledge of protein half-lives or on knowledge of the rate of
different types of reactions in cells (e.g. phosphorylation occurs over a
time-scale of minutes). Since it is not possible to obtain exact
measurements for the parameters in this model we carried out a
parameter scan to see which parameters affected the steady state of the
system under normal conditions using a deterministic version of the
model in COPASI [25]. Each parameter was scanned over ten values
ranging from half to double its initial value. The results of the
parameter scans indicate that altering values of the majority of
parameters over a two-fold range have little effect on the steady state of
the system under normal conditions. The parameters which did affect
the system are shown in Table 3 and are those involved in protein
turnover, misfolding and folding, basal turnover of Hsp70 and Hsp90,
and turnover of ROS. The parameters which have the greatest effect
on the levels of misfolded protein are kmisfold, krefold, kgenROS and kremROS.
The model suggests that the best way to reduce levels of misfolded
protein is to lower levels of ROS. The kinetics of p38 phosphorylation/
de-phosphorylation also have a small effect on pools of NatP,MisP and
free pools of Hsps due to its effect on ROS levels (Table 3). The
parameters which had more than a 10% effect on protein pools were
also examined using the stochastic model (Table 4). As it is necessary to
do repeat simulations, we just examined the effect of doubling the value
of each parameter and calculated the mean values from 20 repeat
Figure 6. Simulation results for a continuous increase in ROS levels over time. The rate of ROS production was set to be an increasing
function of time. One typical simulation showing a cell which underwent apoptosis at time t = 32.3 h. Note that the curves flatten after cell death as
all reactions rates are set to zero. A Native protein, total misfolded protein (includes misfolded bound by Hsps), and reactive oxygen species (ROS).
ROS are scaled x100 to allow easier visualisation. B Total Hsp90 (free pools plus all complexes), Free Hsp90 (unbound Hsp90) and Hsp90_MisP (Hsp90
bound to misfolded protein). C Total Hsp70 (free pools plus all complexes), Free Hsp70 (unbound Hsp70) and Hsp70_MisP (Hsp70 bound to
misfolded protein).
doi:10.1371/journal.pone.0022038.g006
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simulations. The results are very similar to the deterministic model
(compare Tables 3 and 4).
2. Parameter scan for model under conditions of high
stress. We also looked at the effect of parameters under
conditions of high stress by doing a parameter scan on the
model with increasing ROS levels. As this model does not produce
a steady state until death occurs, we looked at the effect of a two-
fold increase in the parameter value on the time to cell death
which the deterministic model predicts to take place at 38.8 hours.
(Note that this does not equal the median time to cell death in the
stochastic model as mentioned previously). The parameters which
have the greatest effect on the time to cell death are kp38death,
kJnkdeath, kp38act and kremROS (Table 5). The first three of these
parameters decrease the time to cell death by more than 20% (i.e
death occurs before 31.3 hours), whereas a two-fold increase in
kremROS delays cell death by about 40% (death occurs at about
53.8 hours). Table 5 shows all the parameters which have more
than a 1% effect on the time to cell death. These parameters are
either involved in ROS turnover, cell death pathways, or protein
misfolding and aggregation.
3. Global parameter scan for model under normal
conditions. In order to further examine the sensitivity of the
model to changes in parameter values a global parameter scan in
which each parameter was varied simultaneously was carried out
using the deterministic model. As the model contains 60
parameters, we generated 50 sets of parameters in which each
parameter was randomly assigned a value between half and double
its initial value. Each model was run in COPASI and the results
Figure 7. Simulation results for a continuous increase in ROS levels over time when p38 and JNK death pathways are inhibited. A–F
Results from six different simulation runs. Aggregated protein sequestered into inclusion bodies (SeqAggP) and aggregated protein bound to
proteasomes (AggP_Proteasome). Vertical dashed green line indicates time of cell death due to proteasome inhibition.
doi:10.1371/journal.pone.0022038.g007
Table 2. Model Events.
Name Trigger Assignments
DeathOfCell CellDeath .= 1.0 kalive= 0
incROS t.14400.0 ROS= 40; kgenROS = 0.04
decROS t.18000.0 ROS= 10; kgenROS= 0.01
Hsp90Inhibition t.3600.0 kbinHsf1Hsp90= 0;
krelHsp90client= 0;
krelAktHsp90= 0
doi:10.1371/journal.pone.0022038.t002
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were analysed and plotted in R. The full results are given in the
supplementary information (Text S1 and Table S1) and
summarised in Table 6. This shows that there are two main
types of effect, either increases in Hsps with an increase in NatP
and decrease in total MisP or decreases in Hsps with a decrease in
NatP and increase in total MisP. The first group is normally
associated with a decrease in ROS and the second with an increase
in ROS. Closer examination of the parameter sets that produced
these results reveal that in the sets with large changes in the
variables, there are large changes in some of the more sensitive
parameters in the model which are given in Table 4. For example,
the sets in which levels of NatP and Hsps decrease and MisP
increases have larger values for the rate of misfolding, and the
amount of MisP increases further if the parameter for ROS
generation is increased and/or the parameter for ROS removal is
decreased (compare parameter Set 1 and Set 6 in the
supplementary information Text S1).
Discussion
Neurodegeneration is an age-related disorder which is char-
acterised by the loss of a subset of neurons in specific regions of the
brain and the accumulation of aggregated protein. The proteins
involved and the regions of the brain affected are dependent on
the particular disease which suggests that stochastic effects may
play an important role. Despite individual differences, there seems
to be common mechanisms involved which involve loss of protein
homeostasis due to cellular systems for removing and repairing
damage being overwhelmed. We built a stochastic model to
investigate the processes involved, focussing on the role of Hsp70
and Hsp90 in preventing both protein aggregation and cell death.
We extended the chaperone model of Proctor et al. [12] to include
the molecular chaperone Hsp70, clients of Hsp70 and Hsp90 and
apoptotic pathways. We used the model to examine the effects of
transient moderate stress and the effects of a gradual increase in
stress over time to reflect the ageing process. The model predicts
that protein homeostasis can be maintained during short periods
of stress due to the abundance of chaperones in cells and the fact
that misfolded protein competes with clients for Hsps when free
pools become diminished. So upregulation of Hsps is not necessary
for short periods of stress. This was an unexpected result as we had
predicted that chaperones would be upregulated after transient
moderate stress (Figure 2). However, there are large pools of free
Hsps under normal conditions making upregulation unnecessary
unless the stress is severe or prolonged.
Under very long periods of stress, the chaperone system
eventually becomes overwhelmed as the upregulation of Hsps
cannot keep pace with the increasing demand of protein
misfolding. This is consistent with experimental data described
in the Introduction, which show that the capacity of chaperone
systems can be exceeded under conditions of high external stress
[22,23]. As the chaperone system becomes overwhelmed there is a
decline in free pools of the anti-apoptotic Hsp70 and so the
probability of cell death pathways being activated increases
leading to neuronal loss.
Since neuronal loss has many adverse effects on brain function,
a potential therapeutic target is to inhibit cell death pathways. This
could be achieved by the use of JNK or p38 inhibitors. However,
the model shows that inhibiting either or both of these pathways
may delay cell death but that cell death will still ultimately occur
via other apoptotic pathways. For example, p53 which is normally
rapidly turned over by the proteasome may start to accumulate if
aggregated protein inhibits proteasomal function. Indeed, the
model predicts that preventing cell death does not stop the
aggregation process and eventually cells will die due to proteasome
inhibition. The model predicts that if aggregates are sequestered
into inclusion bodies, then cell death is less likely to occur although
it is necessary for inclusions to form before aggregates start binding
to the proteasome. However, it is likely, that high levels of
inclusions will also result in cell death [26], and so even if it is
possible to manipulate this pathway, it may not be beneficial.
Therefore, we suggest that any intervention to inhibit cell death
Table 3. Results of parameter scan for deterministic model
under normal conditions.
Parameter NatP Total MisP Free pool of
Hsp70
Free pool of
Hsp90
ksynNatP q 0.079 q 0.075 Q 0.018 Q 0.018
kmisfold Q 0.110 q 0.798 Q 0.172 Q0.173
kbinMisPProt Q 0.058 Q0.146 q 0.037 q 0.036
krefold q 0.060 Q 0.432 q 0.096 q 0.096
kbasalsynHsp70 « 0.000 Q 0.002 q 0.160 q 0.014
kbasalsynHsp90 « 0.000 Q 0.002 q 0.014 q 0.131
kbinHsp70Prot « 0.000 q 0.002 Q 0.152 Q 0.015
kbinHsp90Prot « 0.000 q 0.002 Q 0.016 Q 0.131
kgenROS Q 0.108 q 0.799 Q 0.176 Q 0.177
kremROS q 0.064 Q 0.481 q 0.108 q 0.109
kphosp38 Q 0.005 q 0.033 Q 0.007 Q 0.007
kdephosp38Mkp1 q 0.002 Q 0.017 q 0.004 q 0.004
Each parameter was scanned over 10 values ranging from half to double its
initial value over a period of 10 hours. The results show the effect of increasing
the parameter from its initial value on the pools of NatP, MisP (including MisP
bound to Hsps and the proteasome), free pools of Hsp70 and free pools of
Hsp90. The arrows show the direction of change, the numbers indicate the
proportional change in the species value when the parameter value is doubled
((DX=X )=(Dk=k)), where the denominator is equal to one, if the parameter
value k is double). Effects which are greater than 10% are indicated in boldface.
doi:10.1371/journal.pone.0022038.t003
Table 4. Results of parameter scan for stochastic model
under normal conditions.
Parameter NatP
Total
MisP
Free pool
of Hsp70
Free pool of
Hsp90
kmisfold Q 0.114 q 0.864 Q 0.172 Q0.173
kbinMisPProt Q 0.063 Q0.173 q 0.037 q 0.036
krefold q 0.057 Q 0.444 q 0.096 q 0.096
kbasalsynHsp70 Q 0.006 q0.027 q 0.157 « 0.000
kbasalsynHsp90 Q 0.006 q0.027 q 0.014 q 0.131
kbinHsp70Prot Q 0.006 q 0.032 Q 0.164 Q 0.028
kbinHsp90Prot Q 0.006 q 0.008 Q 0.014 Q 0.135
kgenROS Q 0.108 q 0.752 Q 0.164 Q 0.169
kremROS q 0.063 Q 0.492 q 0.107 q 0.107
Each parameter was increased to double its initial value and 20 repeat
simulations were carried out over a 10 hour period. The results show the effect
on the mean values of NatP, MisP (including MisP bound to Hsps and the
proteasome), free pools of Hsp70 and free pools of Hsp90. The arrows show the
direction of change, the numbers indicate the proportional change in the
species value when the parameter value is doubled ((DX=X )=(Dk=k)), where
the denominator is equal to one, if the parameter value k is double). Effects
which are greater than 10% are indicated in boldface.
doi:10.1371/journal.pone.0022038.t004
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pathways also needs to be able to reduce protein misfolding and
aggregation either by enhancing clearance systems or by reducing
levels of stress within cells. Our models indicate that the latter
strategy may be particularly beneficial.
Although it is generally accepted that an increase in ROS-
mediated macromolecular damage contributes to ageing, a causal
relationship between ROS and proteotoxicity is still controversial. It
has been suggested that an increase in oxidative damage with age
could be due to an age-related increase in ROS production [27],
although other possibilities include a decline in the efficiency of
antioxidant systems or an increase in damaged mitochondria which
produce more ROS. An increase in ROS with time can be modelled
by either increasing the rate of ROS production or decreasing the
rate of ROS removal over time. The outcome in the model would be
the same and we chose to allow the level of ROS to slowly increase
linearly with time. It might be preferable to include mitochondria in
the model and then to use ROS generation from the mitochondria as
an input instead of the reaction for ROS generation. This would add
further complexity to the model but would provide a more complete
picture of the processes involved. In addition a constant pool of ATP
could be replaced by reactions of ATP production and consumption
where the production rate depends on the state of the mitochondria,
e.g. damaged mitochondria produce less ATP. This would be an
interesting future development of the current model. Other
perturbations which could be carried out in the current model
include examining a lowered efficiency of Hsf1 transcription or a
decline in proteasome efficiency with age.
The model developed here makes several predictions that are
potentially testable using cell culture and animal models. In
general there is relatively little information in the chaperone
literature on the extent to which various chaperone pools are
engaged in the folding process [28]. Kamal et al. have compared
the extent to which Hsp90 is complexed with cochaperones in
normal and tumor cells, using this as a marker of Hsp90
engagement with client proteins [29]. These experiments suggest-
ed that only a small fraction of Hsp90 in normal cells is actively
engaged in protein folding. It would be interesting to perform
similar analyses on cells in which ROS levels have been
manipulated experimentally. This might give quantitative exper-
imental data on levels of total and free Hsp90 which could then be
compared with model predictions.
Many potential therapeutic strategies for neurodegenerative
disorders are targeting JNK and p38. However, our model
predictions suggest that although these therapies may be useful in
delaying the onset of disease pathology, they will not prevent the
early stages of disease or its progression. For example the model
predicts that inhibition of p38 and JNK will delay cell death but
that eventually inhibition of proteasomes by aggregated protein
will cause death in a significant proportion of cells. Previous studies
on the role of p38 and JNK have only assessed apoptosis at a short
time interval after initiation of protein misfolding in cells and thus
are compatible with this model. Assessing apoptosis at longer
intervals after initiating protein misfolding would provide a test of
this model prediction. This experiment could be performed in the
absence and presence of constitutively-active Hsf1 to determine
whether a combination of stress-activated protein kinase inhibition
and enhancement of chaperone activity is more effective at
inhibiting apoptosis than either treatment alone. This would give
Table 5. Results of parameter scan for deterministic model with increasing ROS over time.
Size of effect
Parameters which
delay cell death
Predicted time of
cell death (hours)
Parameters which
hasten cell death
Predicted time of
cell death (hours)
30–40% kremROS 53.8
20–30% kp38death 30.4
20–30% kJnkdeath 30.5
20–30% kp38act 30.1
10–20% kdephosJnkMkp1 44.9 kphosJnk 33.1
10–20% kdephosp38Mkp1 45.0 kphosp38 32.9
5–10% kmisfold 36.7
5–10% kgenROS 36.6
1–5% kbinMisPProt 39.3 kagg 38.5
1–5% kgenROSp38 38.4
1–5% kPIdeath 38.6
The results show the effect of a two-fold increase in the parameter value on time to cell death (predicted time to cell death for default parameters = 38.8 hours).
doi:10.1371/journal.pone.0022038.t005
Table 6. Summary of global parameter scan results.
ROS Q ROS q ROS « (,5% change)
NatP q, Hsps q, MisP Q 19 2 2
NatP Q, Hsps Q, MisP q 3 15 1
NatP «, Hsps «, MisP q 1 1 0
NatP «, Hsps «, MisP Q 1 1 0
Less than 10% change in NatP, Hsps and MisP 4 0 0
doi:10.1371/journal.pone.0022038.t006
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insights into whether a combination of therapeutic strategies such
as increasing chaperone activity to reduce protein aggregation and
inhibiting p38 and JNK pathways would be beneficial. Other
therapies that could be tested in combination with JNK or p38
inhibitors are the use of antioxidants to reduce protein damage
and aggregation, or Hsp90 inhibitors which would reduce
aggregation by increasing chaperone activity and reducing levels
of mutant tau and may also have effects on apoptosis by reducing
the level GSK3b. As recently suggested by Lindner & Demarez,
merging predictive modelling and quantitative experimentation
will bring new breakthroughs in our understanding of the ageing
process [30].
Although the model is quite complex, it is still a simplification of
the cellular system and it may be desirable to add in further detail
in order to determine the main pathways involved in maintaining
protein homeostasis. The level of detail chosen in the current
model was based on the current knowledge of the system and the
relevance to ageing especially in the context of neurodegeneration.
The model was built in SBML, a computer readable format for
representing computer models of biological processes. SBML
models can be used by an extensive variety of software tools
without the need for recoding the model which means that models
can be easily shared and adapted by other users. Therefore, the
model can easily be adapted by other users and it will be straight
forward to add further detail as new information about the system
emerges. It is also possible to remove some of the current detail.
For example the reactions involving Akt could be removed and
then we would assume that Akt is one of the generic Hsp90 clients.
In fact removing these reactions did not affect the qualitative
behaviour of the model but we chose to include them as it gave
insights into the effect of Hsp90 inhibition on Hsp90 clients. Since
Akt levels declined when Hsp90 is inhibited we would expect that
other clients such as GSK3b and mutant tau would also decline.
Therefore we predict that inhibition of Hsp90 might lead to less
cell death even though the current model does not show this. On
the other hand Akt inhibits GSK3b activity and so the effect of
Hsp90 inhibition on GSK3b is not entirely clear and requires
further investigation. An important future extension to the model
is the addition of GSK3b and tau. Both proteins are linked to Akt
since Akt phosphorylates GSK3b and it has been shown that Akt
plays an important role in regulating tau degradation [31]. As well
as the chaperone system, the ubiquitin-proteasome system plays an
important role by removing damaged and misfolded proteins. Our
model includes protein degradation but does not have detail of the
ubiquitination steps. A model of the ubiquitin-proteasome has also
been developed by Proctor et al. [32] and since this model was also
coded in SBML, it will be possible to link the models together in
order to explore the interactions between the chaperone and
proteasome pathways in more detail. Hsp70 and Hsp90 are both
degraded via CHIP and it may be important to add further detail
of these degradation pathways. The molecular chaperone Hsp27
(P04792) is also important in preventing protein aggregation and is
also anti-apoptotic. It predominantly exists as oligomers which
have chaperone activity, but in stressed conditions oligomers are
disrupted by phosphorylation of Hsp27 to form monomers and
dimers. One of the kinases involved is p38 which as previously
mentioned is itself activated by stress. Hsp27 oligomers also have a
role in modulating ROS levels by induction of glutathione levels. A
separate model of Hsp27 is currently being developed and this will
be incorporated into the model of Hsp70 and Hsp90 to provide a
more complete model of the chaperone system.
Our current model includes generic pools of Hsp70 and Hsp90
clients and also some specific clients such as Akt. As already
mentioned, another client of Hsp90 which plays an important role
in neurodegeneration is (GSK3b) which is involved in phosphor-
ylation of tau, production of amyloid beta (Ab (P05067)), and
modulates apoptotic pathways (reviewed in [33,34]). It also
interacts with p53 and activity of both proteins is increased as a
result of this interaction [35]. A stochastic model of the role of
GSK3b and p53 has been developed [36] and so it will be of great
interest to add GSK3b to the chaperone model and then link the
models together to examine the effect of Hsp90 inhibition on the
aggregation kinetics of tau and Ab. We assumed that JNK and p38
were both directly activated by ROS. Recent data suggests that the
catalytic Cys residue Mkp1 is oxidised and so deactivated by ROS
[37]. Therefore we also assumed that Mkp1 deactivation depends
on ROS levels and so an increase in ROS may lead to reduced
dephosphorylation of JNK and p38. However, ROS also induces
upregulation of Hsp70 which results in more active Mkp1. Our
model predicts that increasing ROS leads to inactivation of Mkp1
as the increased pools of Hsp70 are required by the increased
levels of misfolded protein.
Our model uncovers three main principles about the system.
The first is that oxidative stress is the main trigger for the loss in
protein homeostasis and so reducing stress is the key to preventing
the initiation of the disease process. The second principle is that
the ability of the cell to deal with stress via the chaperone and
degradation pathways is important especially over long time scales
as misfolded and aggregated protein will accumulate and then
disease progression is difficult to halt. Finally, inhibiting cell death
pathways allows longer cell survival but cannot prevent the
aggregation process which will also ultimately lead to cell death.
To summarise, we have developed a mechanistic model of the
chaperone system to investigate how loss of protein homeostasis
may lead to protein aggregation and cell death, both character-
istics of neurodegeneration. We mainly used stochastic simulation
so that cellular variability can be examined and the relationship
between protein aggregation and cell death can be explored. The
model made several predictions and the next stage will be to test
these experimentally using cell culture or animal models. One
important prediction is that inhibiting either the JNK or p38 cell
death pathway may delay cell death but does not stop the
aggregation process so that eventually cells die due to aggregated
protein inhibiting proteasomal function. In addition to the
chaperone system modelled here, the ubiquitin-proteasome
system, lysosomal pathways, and mitochondria are involved in
age-related neurodegeneration. Mathematical models of these
other cellular mechanisms are currently being developed by the
authors and will provide the building blocks of an integrative
model. This will increase our understanding about how different
processes interact to produce systemic outcomes.
Methods
Building the stochastic model
We modified our previous model of Hsp90 [12] which modelled
the role of Hsp90 in maintaining protein homeostasis. The earlier
model was encoded in the SBML [13] and so is easily modified. As
in our previous model, we assume that there is a pool of proteins
which are in their native conformation (NatP) but that these
proteins are continuously subjected to damage which results in
misfolding. There are three outcomes for misfolded proteins
(MisP). Firstly, the molecular chaperones Hsp70 and Hsp90 bind
to MisP to prevent their aggregation and an attempt is made to
refold the proteins in an ATP-dependent reaction. Secondly,
Hsp70 or Hsp90 will transport misfolded protein to the ubiquitin-
proteasome system for degradation, although we do not include
details of the ubiquitination steps as previously modelled [32].
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Lastly the misfolded proteins may aggregate to form a small
aggregate (AggP). Further misfolded protein may then bind to a
small aggregate to form a larger aggregate (Seq AggP) which we
will also refer to as an inclusion body. Small aggregates may bind
to the proteasome and inhibit proteasomal function (AggP_Pro-
teasome) and may also increase the generation of ROS. We
assume that SeqAggP does not interfere with the cellular
machinery and is a means to isolating the toxic aggregates. We
also assume that Hsp70 and Hsp90 may be damaged by ROS and
that damaged forms lose their chaperone activity and may form
small aggregates or be sequestered into inclusion bodies in a
similar way to misfolded protein.
Hsp70 and Hsp90 both have many client proteins which bind
with high affinity to form complexes, but are constantly
undergoing cycles of assembly and disassembly. We represent
these clients with generic pools named Hsp70Clients and
Hsp90Clients.
We also include the Hsp90 client Akt since this kinase is
important in many pathways and so provides a link to other
models. In addition, there is experimental data on the half-life of
Akt and how this is affected by Hsp90 inhibition providing useful
information for the parameters involved in Akt turnover. Hsp90
binds Heat Shock transcription Factor-1 (Hsf1) which keeps Hsf1
in its inactive monomeric state which we include as a separate
species. Under conditions of stress, an increase in misfolded
protein sequesters Hsf1 from Hsp90 and the increase in the pool of
unbound Hsf1 enables dimerisation and trimerisation to take
place. Hsf1 trimers are then phosphorylated by a protein kinase
(PKC, (IPR015745)) which makes Hsf1 transcriptionally active.
Hsf1 trimers can bind to the Heat Shock Element (HSE) in either
their phosphorylated or un-phosphorylated state but only the
former binding leads to transcription of heat shock proteins. We
also include basal synthesis and degradation of Hsp70 and Hsp90.
Among the clients for Hsp70 is the currently unknown
phosphatase responsible for dephosphorylating Hsf1 trimers, (which
we name PPX). We assume that under normal conditions PPX is in
complex with Hsp70 and so Hsf1 trimers are in their unpho-
sphorylated state. Hsp70 also activates the phosphatase Mkp1
which is responsible for dephosphorylating JNK and p38 [38].
When free pools of Hsp70 are high, Mkp1 is in its active state, but if
Hsp70 pools are depleted, Mkp1 becomes inactivated and so JNK
and p38 are more likely to be in a phosphorylated state. Under
conditions of stress misfolded protein binds preferentially to Hsp70
leading to an increase in phosphorylated JNK and Hsf1 trimers.
This leads to an increase in the transcription of heat shock genes. If
JNK remains in a phosphorylated state, it will contribute to
apoptotic signalling. However, if Hsp70 levels increase due to the
transcriptional activity of Hsf1, then JNK will be de-phosphorylated
before apoptotic signalling takes place. We assume that JNK and
p38 are both phosphorylated in response to signalling via ROS, so if
ROS levels are high as a result of an increase in stress, the rate of
phosphorylation increases.
A list of species and reactions are shown in Tables 7 and S2
respectively. The model was encoded in SBML shorthand and
converted to full SBML [39]. It was then imported into the BASIS
modelling system [40] and simulations were run using a stochastic
simulator based on the Gillespie algorithm [41]. To keep the
model simple, we have not included detail of the apoptotic
pathways. Models of apoptosis will be developed separately and
then linked to this model if required. Instead, we assume that a cell
will die if any of the following three conditions occur. The first two
conditions involve activation of either JNK or p38, where we
assume that the probability of cell death increases as pools of
activated JNK or p38 increase. The third condition is inhibition of
the proteasome where we assume that as the pool of AggP_Pro-
teasome increases (and hence the available pool of proteasomes
decreases) the probability of cell death increases. These conditions
are modelled by reactions in SBML and the details are given in
Table S2. Note that since the model is stochastic, cell death may
occur even when pools of activated JNK or p38 are fairly low but
with a very low probability. When a death reaction occurs, a
dummy species is set to one, so that cell deaths can be counted
according to type. A dummy parameter kalive is present in all the
reactions and is initially set to one. When a cell death occurs, the
parameter is set to zero so that no more reactions can take place in
the simulation. This is achieved by using SBML event structures
(Table 2). The SBML code is available from the BASIS website
[42], and a fully annotated version can be obtained from the
Biomodels database (MODEL1005280000) [43,44]. The code is
also available in Code S1 in the supplementary materials.
Simulation results were analysed and plotted using R.
Use of stochastic and deterministic models
Stochastic effects are very important in this model under
conditions of moderate or high stress. In particular the timing of
when the aggregation process starts, the destination of aggregates
(inhibition of the proteasome or sequestered into inclusion bodies),
the levels of ROS and the timing of cell death show large
variations between simulation runs. However, stochastic simula-
tions are very computer intensive and for conditions of high stress
a set of 100 repeat runs takes about one week if run on a PC or
about 24 hours if run on the BASIS cluster. Therefore it is not
feasible to use a stochastic model to carry out a full parameter
scan. To overcome this problem we also developed a deterministic
model and ran simulations in CellDesigner and COPASI. We used
the same initial conditions and parameter values for the
deterministic model so that direct comparisons could be made.
The rate laws for dimerisation reactions were adjusted, for
example kdimerHsf1,#Hsf1.,#Hsf1-1./2.0 was changed to
kdimerHsf1Hsf1
2.
Initial amounts of species
Proteins are present in very large numbers in cells. For example,
experimental values of the number of p38 molecules per cell has
been estimated as 106 molecules per cell [45]. As we are using
stochastic simulation, it is not practical to have starting values in
this order of magnitude due to the amount of time that would be
required to carry out even a single simulation. Therefore it is
necessary to scale down the values of model species. The
motivation for the model was to examine the qualitative behaviour
of the system and as information on initial amounts for the
majority of species is not available we have assumed that most
species are present in relatively similar abundances but that Hsps
are an order of magnitude more abundant than kinases, and the
generic pool of NatP was set to be two orders of magniture more
abundant as this represents many different proteins. We used a
constant value of 104 molecules/cell for ATP since our model
includes only a small fraction of the reactions requiring ATP and it
does not seem appropriate to assume that ATP levels would be
rate limiting in this model. We assumed that the cell volume is
equal to one so that all initial amounts represent the number of
molecules per cell and so we used the same initial values in the
deterministic simulations.
Parameter values
One of the most difficult parts in the model building process is
finding values for all the parameters as kinetic data is often not
available. Where kinetic data is available, it is often from in vitro
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Table 7. List of Species.
Species description Species Name Database term Initial Amount
Native protein NatP CHEBI:36080 17600
Misfolded protein MisP CHEBI:36080 0
Aggregated protein AggP CHEBI:36080 0
MisP bound to Hsp70 Hsp70_MisP IPR001023, CHEBI:36080 470
MisP bound to Hsp90 Hsp90_MisP IPR001404, CHEBI:36080 410
Hsp70 Hsp70 IPR001023 1400
Hsp90 Hsp90 IPR001404 1850
Damaged Hsp70 Hsp70_dam IPR001023 0
Damaged Hsp90 Hsp90_dam IPR001404 0
Hsp70 bound to proteasome Hsp70_Proteasome IPR001023, GO:0000502 0
Hsp90 bound to proteasome Hsp90_Proteasome IPR001404 GO:0000502 0
Hsf1 Hsf1 Q00613 5
Hsf1 bound to Hsp90 Hsf1_Hsp90 Q00613, IPR001404 95
Hsf1 dimers Hsf1_Hsf1 Q00613 0
Hsf1 trimers Hsf1_Hsf1_Hsf1 Q00613 0
Phosphorylated Hsf1 trimers Hsf1_Hsf1_Hsf1_P Q00613 0
Hsp70 heat shock element HSEHsp70 SBO:0000369 2
Hsp90 heat shock element HSEHsp90 SBO:0000369 2
Phosphorylated Hsf1 bound to HSEHsp70 HSEHsp70_Hsf1_Hsf1_Hsf1_P SBO:0000369, Q00613 0
Unphosphorylated Hsf1 bound to HSEHsp70 HSEHsp70_Hsf1_Hsf1_Hsf1 SBO:0000369, Q00613 0
Phosphorylated Hsf1 bound to HSEHsp90 HSEHsp90_Hsf1_Hsf1_Hsf1_P SBO:0000369, Q00613 0
Unphosphorylated Hsf1 bound to HSEHsp90 HSEHsp90_Hsf1_Hsf1_Hsf1 SBO:0000369, Q00613 0
Hsp70 client proteins Hsp70Client CHEBI:36080 490
Hsp90 client proteins Hsp90Client CHEBI:36080 590
Hsp70 bound to clients Hsp70_Hsp70Client IPR001023, CHEBI:36080 10
Hsp90 bound to clients Hsp90_Hsp90Client IPR001404, CHEBI:36080 10
Akt (protein kinase B) Akt P31749 340
Akt bound to Hsp90 Akt_Hsp90 P31749, IPR001404 30
Carboxy terminus of Hsp70-interacting protein CHIP Q9UNE7 255
Akt bound to CHIP/Hsp90 complex Akt_CHIP_Hsp90 P31749, Q9UNE7, IPR001404 80
Akt bound to proteasome Akt_Proteasome P31749, GO:0000502 0
Proteasome Proteasome GO:0000502 500
MisP bound to proteasome MisP_Proteasome CHEBI:36080,GO:0000502 0
Aggregated protein bound to proteasome AggP_Proteasome CHEBI:36080, GO:0000502 0
Sequestered aggregated protein SeqAggP CHEBI:36080 0
Phosphatase Mkp1 (DUSP1) Mkp1 P28562 0
Phosphorylated Mkp1 Mkp1_P P28562 100
Mkp1 bound to proteasome Mkp1_Proteasome P28562, GO:0000502 0
Phosphatase for Hsf1 Ppx GO:0008287 0
PPX bound to Hsp70 Hsp70_Ppx IPR001023, GO:0008287 100
JNK (MAPK8) Jnk P45983 100
Phosphorylated JNK Jnk_P P45983 0
p38MAPK (MAPK14) p38 Q16539 100
Phosphorylated p38MAPK p38_P Q16539 0
Protein kinase C Pkc IPR015745 100
Reactive oxygen species ROS CHEBI:26523 10
Adenosine triphosphate ATP CHEBI:15422 10000
Adenosine diphosphate ADP CHEBI:16761 1000
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systems which may not accurately reflect the in vivo kinetics. Also
kinetic parameters are often dependent on cell type. However,
even if exact values are not easy to obtain, it is often satisfactory to
know the relative time scales of the reactions. For example, kinase/
phosphatase reactions are very fast reactions occurring over
timescales that range from fraction of a second to seconds, whereas
protein synthesis takes several minutes. Degradation rates are
dependent on protein type but fortunately, there is usually
information available on protein half-lives which can be used to
calculate the degradation rate. Note that the half-life of a protein is
dependent on the rate at which the protein is targeted for
degradation rather than on the rate of proteasome activity which
we assume to be independent of protein type (apart from
aggregated protein which we assume is totally resistant to
degradation by proteasomes). So we set the rate at which a
particular protein binds to the proteasome to be equal to –ln(0.5)/
t0.5, where t0.5 is the protein half-life. As an example we assume
that the half-life of Hsp70 is about 30 hours, so that kbinHsp70Prot
* Proteasome =2ln(0.5)/108000s. Since the pool of proteasomes
is about 500, then kbinHsp70Prot =1.2610
28. We then set the basal
synthesis rate, so that total Hsp70 pools remain constant under
normal conditions. We set the parameters for aggregation to be
very low, since it has been shown that there is a very long lag phase
before aggregates start to form and also we would not expect
aggregation to take place under normal conditions. Once we had
chosen a set of parameters, we then simulated the model under
normal conditions and checked that all species remained fairly
constant over time. As the model is stochastic we would expect
variations in protein levels over time but there should be no
obvious trend of an increase or decrease in these levels. If such a
trend was observed, we made the necessary adjustments to the
parameter values. We also checked the model by doing 100 repeat
simulations and plotting the mean values, and in addition ran the
model in a deterministic simulator using CellDesigner [46]. We
carried out parameter scans for all the parameter values using
COPASI [25] (see Results section).
Model validation
After choosing the parameters for normal conditions, we then
validated the model against experimental data for the heat shock
response. We do not have temperature as a variable in our model,
however the transient increase in ROS levels has a similar effect to
increasing the temperature for a specified time period. Kline &
Morimoto et al measured the dynamics of phosphorylated Hsf1,
binding of Hsf1 to HSE and the transcription rate of Hsp70 after
heat-shock of HeLa cells at 42uC for 250 minutes [47]. They
observed a rapid activation of all three variables between 0 and 35
minutes after the stress with a attenuation back to basal levels over
the next ,200 minutes. Note that the attenuation phase begins
during the continued heat-shock exposure. We examined the
dynamics of the same variables from our simulation output under
conditions of ROS increase for 4 hours. The model predicts that
there is a rapid activation of all three variables which begins about
1 minute after the start of the stress response, reaches a maximum
after about 1–2 hours and then attenuates back to basal levels over
the next 2 hours with the attenuation phase beginning during the
period of elevated ROS (data not shown). The attenuation phase
starts even though ROS is still elevated due to the increase in levels
of Hsp70 which will bind to PPX resulting in dephosphorylation of
Hsf1 trimers. The qualitative behaviour of our model is in good
agreement with the experimental data showing that the model
captures the important features of the stress response.
Supporting Information
Figure S1 Diagram of the model. Numbers on the arrows refer
to the reaction numbers in Table S2. Note that some reactions are
omitted for clarity where similar reactions occur as noted in the
footnotes to Table S2.
(TIF)
Figure S2 Mean of 100 runs for normal conditions. A Native
protein, total misfolded protein (includes misfolded bound by
Hsps), and reactive oxygen species (ROS). ROS are scaled x100 to
allow easier visualisation. B Total Hsp90 (free pools plus all
complexes), Free Hsp90 (unbound Hsp90) and Hsp90_MisP
(Hsp90 bound to misfolded protein). C Total Hsp70 (free pools
plus all complexes), Free Hsp70 (unbound Hsp70) and
Hsp70_MisP (Hsp70 bound to misfolded protein).
(TIF)
Figure S3 Deterministic simulation for normal model. A Native
protein, total misfolded protein (includes misfolded bound by
Hsps), and reactive oxygen species (ROS). ROS are scaled x100 to
allow easier visualisation. B Total Hsp90 (free pools plus all
complexes), Free Hsp90 (unbound Hsp90) and Hsp90_MisP
(Hsp90 bound to misfolded protein). C Total Hsp70 (free pools
plus all complexes), Free Hsp70 (unbound Hsp70) and
Hsp70_MisP (Hsp70 bound to misfolded protein).
(TIF)
Figure S4 Deterministic simulation for model with transient
stress. A Native protein, total misfolded protein (includes misfolded
bound by Hsps), and reactive oxygen species (ROS). ROS are
scaled x100 to allow easier visualisation. B Total Hsp90 (free pools
plus all complexes), Free Hsp90 (unbound Hsp90) and
Hsp90_MisP (Hsp90 bound to misfolded protein). C Total
Hsp70 (free pools plus all complexes), Free Hsp70 (unbound
Hsp70) and Hsp70_MisP (Hsp70 bound to misfolded protein).
(TIF)
Figure S5 Graph to show how ROS levels increase with time.
Black line shows rate of ROS production versus time, red and
green curves show ROS levels for two stochastic simulations.
Horizontal part of curve corresponds to cell death.
(TIF)
Figure S6 Deterministic model for ROS increasing with time. A
Native protein, total misfolded protein (includes misfolded bound
by Hsps), and reactive oxygen species (ROS). ROS are scaled x100
to allow easier visualisation. B Total Hsp90 (free pools plus all
IPR: InterPro [48].
GO: Gene ontology [49].
CHEBI: Chemical Entities of Biological Interest database [50].
P and Q: Uniprot [51].
SBO: Systems Biology Ontology [52].
doi:10.1371/journal.pone.0022038.t007
Table 7. Cont.
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complexes), Free Hsp90 (unbound Hsp90) and Hsp90_MisP
(Hsp90 bound to misfolded protein). C Total Hsp70 (free pools
plus all complexes), Free Hsp70 (unbound Hsp70) and
Hsp70_MisP (Hsp70 bound to misfolded protein).
(TIF)
Figure S7 Effect of varying kseqagg. The parameter kseqagg was
varied from half to double of its initial value in the deterministic
model with ROS increasing with time and inhibition of JNK and
p38 death pathways. The parameter scan was carried out in
COPASI and the results plotted in R.
(TIF)
Figure S8 Effect of varying kupregHsp. The parameter kupregHsp was
varied over two orders of magnitude in the deterministic model
with ROS increasing with time and inhibition of JNK and p38
death pathways. The scan was carried out in COPASI and the
results plotted in R.
(TIF)
Table S1 Results of the global parameter scan. Excel spread-
sheet containing full results of 50 randomly chosen parameter sets
and the effects on the model predictions. Sheet 1 contains all the
parameter values for each set. Sheet 2 shows the percentage
difference between each parameter and the default value. Sheet 3
shows the predicted percentage change in mean value for native
protein, total misfolded protein, free pools of Hsp70 and Hsp90,
and ROS for each parameter set.
(XLS)
Table S2 List of reactions. List of all the reactions in the model
including kinetic rate laws and parameter values.
(DOC)
Text S1 Figures for the global parameter scan. Plots showing
levels of native protein, misfolded protein and free pools of Hsp70
and Hsp90 for each of the 50 randomly chosen parameter sets.
The number below each graph corresponds to the parameter set
shown in Table S1.
(PDF)
Code S1
(XML)
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